Skip to content

Partnership-Project - Reinforcing Partnership Between Cancer Patient, General Practitioner and Oncologist During Chemotherapy

Partnership-Project - Reinforcing Partnership Between Cancer Patient, General Practitioner and Oncologist During Chemotherapy - a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02716168
Acronym
PSP
Enrollment
281
Registered
2016-03-23
Start date
2016-05-31
Completion date
2020-08-31
Last updated
2020-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Cancer, tele-health, Shared care, Continuity

Brief summary

Background International guidelines underline the importance of strengthening the coordination and continuity of cancer care. The different roles of general practitioners and oncologists with regard to treatment, follow-up and rehabilitation during and after cancer treatment are often obscure to cancer patients. Parallel courses of healthcare are often taking place instead of coordinated care characterized by continuity and partnership between care providers. Patients may feel uncertain about the health professionals' skills and area of responsibility. Healthcare seeking and support during and after cancer treatment may, therefore, be inappropriate, leaving patients feeling insecure and lost between care providers.The study aims to design and evaluate a new way of communication and shared decision-making that brings the patient, the oncologist and general practitioner together in a shared video-consultation in the early phase of chemotherapeutic treatment. The effect of the intervention in addition to usual care will be tested in a randomized controlled trial at Vejle Hospital in the Region of Southern Denmark. Based on sample size calculation, investigators intent to include 300 patients at the Department of Oncology and their general practitioners. Results and process outcomes will be evaluated qualitatively and quantitatively, questionnaires to patients, general practitioners and oncologists, and data from registers.

Interventions

OTHERShared video consultation between patient, general practitioner and oncologist

At the start of the patients chemotherapy treatment a shared video consultation between the patient, general practitioner and oncologist will bee arranged. The video consultation should address distribution of roles, comorbidity, medicine, depression and anxiety symptoms, relatives and social resources.

Sponsors

National Research Center of Cancer Rehabilitation
CollaboratorUNKNOWN
Research Unit of General Practice, Odense
CollaboratorOTHER
Vejle Hospital
CollaboratorOTHER
Region of Southern Denmark
CollaboratorOTHER
Odense Patient Data Explorative Network
CollaboratorOTHER
University of Southern Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Newly referred cancer patient scheduled for chemotherapy at the Department for Oncology, Vejle Hospital, Region of Southern Denmark * Aged 18 years and over * Able to speak and read Danish * Mentally able to cooperate * Listed with a general practitioner (98 % of the danish population) * Written and verbal informed consent given

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Shared Care questionnaire7 month after inclusionPatient reported outcome measure. Cancer patients assessment of their cancer trajectory and their assessment of the cooperation between their General Practitioner and the oncologist specialist.

Secondary

MeasureTime frameDescription
European Organisation for Research and Treatment of Cancer - Quality of Life questionnaire - Core 30 (EORTC QLQ C30)4 and 7 month after inclusionPatient reported outcome measure. Cancer patients assessment of their quality of life
European Organisation for Research and Treatment of Cancer - Quality of Life- information questionnaire (EORTC QLQ INFO25)4 and 7 month after inclusion
Generalised Anxiety Disorder Assessment (GAD-7)4 and 7 month after inclusionPatient reported outcome measure. Screening tool and severity measure for generalised anxiety disorder
Patient Health Questionnaire (PHQ-9)4 and 7 month after inclusionPatient reported outcome measure.The questionnaire monitor the severity of depression and response to treatment.
Illness Intrusiveness Rating Scale (IIRS)4 and 7 month after inclusionPatient reported outcome measure. Patients assessment of the cancer disease influence on their daily living.
General practitioners assessment of a video consultation between the patient, General practitioner and oncologist.Directly after the video consultation interventionIt measures the General Practitioners perception of the benefits with the video consultation intervention. Only the intervention group.
Patients assessment of a video consultation between the patient, General practitioner and oncologist.Directly after the video consultation interventionIt measures the patients perception of the benefits with the video consultation intervention.Only the intervention group
General Practitioner cancer trajectory assessment4 month after the inclusion of the patient.The General Practitioners assessment of the cooperation between the primary and secondary care regarding af specific cancer patient.
Oncologist assessment of a video consultation between the patient, General practitioner and oncologist.Directly after the video consultation interventionIt measures the oncologist perception of the benefits with the video consultation intervention. Only the intervention group

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026